1. Home
  2. GFAI vs VYNE Comparison

GFAI vs VYNE Comparison

Compare GFAI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • VYNE
  • Stock Information
  • Founded
  • GFAI 2018
  • VYNE 2003
  • Country
  • GFAI Singapore
  • VYNE United States
  • Employees
  • GFAI N/A
  • VYNE N/A
  • Industry
  • GFAI Diversified Commercial Services
  • VYNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • VYNE Health Care
  • Exchange
  • GFAI Nasdaq
  • VYNE Nasdaq
  • Market Cap
  • GFAI 23.3M
  • VYNE 24.3M
  • IPO Year
  • GFAI N/A
  • VYNE 2018
  • Fundamental
  • Price
  • GFAI $1.11
  • VYNE $0.35
  • Analyst Decision
  • GFAI Strong Buy
  • VYNE Buy
  • Analyst Count
  • GFAI 1
  • VYNE 2
  • Target Price
  • GFAI $4.50
  • VYNE $8.00
  • AVG Volume (30 Days)
  • GFAI 721.9K
  • VYNE 2.9M
  • Earning Date
  • GFAI 09-23-2025
  • VYNE 08-13-2025
  • Dividend Yield
  • GFAI N/A
  • VYNE N/A
  • EPS Growth
  • GFAI N/A
  • VYNE N/A
  • EPS
  • GFAI N/A
  • VYNE N/A
  • Revenue
  • GFAI $36,347,373.00
  • VYNE $605,000.00
  • Revenue This Year
  • GFAI $5.66
  • VYNE $42.51
  • Revenue Next Year
  • GFAI $4.69
  • VYNE N/A
  • P/E Ratio
  • GFAI N/A
  • VYNE N/A
  • Revenue Growth
  • GFAI 0.18
  • VYNE 43.03
  • 52 Week Low
  • GFAI $0.76
  • VYNE $0.34
  • 52 Week High
  • GFAI $3.88
  • VYNE $4.30
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 39.64
  • VYNE 28.44
  • Support Level
  • GFAI $1.27
  • VYNE $0.34
  • Resistance Level
  • GFAI $1.48
  • VYNE $1.60
  • Average True Range (ATR)
  • GFAI 0.11
  • VYNE 0.14
  • MACD
  • GFAI -0.03
  • VYNE -0.12
  • Stochastic Oscillator
  • GFAI 7.14
  • VYNE 1.03

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: